# Allergic Rhinitis Combination Pharmacotherapy Efficacy Study

> **NCT04601324** · PHASE4 · WITHDRAWN · sponsor: **St. Paul's Sinus Centre**

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Fluticasone Propionate
- **DRUG:** Azelastine hydrochloride and fluticasone propionate
- **DRUG:** Rupatadine

## Key facts

- **NCT ID:** NCT04601324
- **Lead sponsor:** St. Paul's Sinus Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-15
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI did not pursue this study
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04601324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04601324, "Allergic Rhinitis Combination Pharmacotherapy Efficacy Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04601324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*